Chattanooga Clinical Site

Chattanooga, Tennessee 37421

0 studies enrolling now · 1 studies all time

What they study most

Irritable Bowel Syndrome (IBS)

Studies at this site

• A Phase 2, Multi-center Study to Evaluate the Efficacy and Safety of ONO-2952 in Female Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D) — Completed